Natalia Dadivanyan, market development manager - pharma small molecule at Malvern Panalytical, explains how manufacturers can keep production moving while maintaining tablet quality.
Following Andy Burnham's meeting with Arichie Goodburn and the announcement of a national brain cancer lead and accelerated MHRA reviews, chief scientific officer at CRISM Therapeutics Chris McConville gave his insight regarding the news.
Antoine Kabre, electrical & controls engineering manager at PSB Industries, shares how historical operating data can turn a shutdown alarm into a starting point for understanding equipment behaviour, identifying recurring problems.
Dan Williams PhD, CEO at SynaptixBio discusses current approaches to delivering drugs into the central nervous system (CNS), focusing on the specific challenges for key therapies like gene-silencing drugs that aim to treat rare neurological diseases.
